Connectyx in Licensing Discussions for Novel Monoclonal Antibody to Treat Pediatric Glioblastoma Boca Raton, FL, July 06, 2020 (GLOBE NEWSWIRE) -- Connectyx Technologies Holdings Group, Inc. (OTC: CTYX) (“Connectyx” or the “Company”), a development-stage biomedical company focusing on novel...

Connectyx Welcomes I. Richard Garr, Esq. to Company’s Scientific Advisory Board Company Reports First Quarter Results Boca Raton, FL, May 19, 2020 (GLOBE NEWSWIRE) -- Connectyx Technologies Holdings Group, Inc. (OTC: CTYX) (“Connectyx” or the “Company”), a development stage...